TCL Archive ABMT Trials Unlikely To show Clean Benefit for Breast Cancer; Data Release Debated March 12, 1999
TCL Archive Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation June 29, 2012